| 1 |
32949176 | Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma. | 2021 Mar |
3 |
| 2 |
33828975 | The Value of Anlotinib in the Treatment of Intractable Brain Edema: Two Case Reports. | 2021 |
1 |
| 3 |
34522456 | Comprehensive identification of FGFR1-4 alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing. | 2021 |
2 |
| 4 |
34692530 | Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification. | 2021 |
2 |